Astec Lifesciences Ltd Analyst Rating
based on 2 analysts
50.00%
Buy
0.00%
Hold
50.00%
Sell
Based on 2 analysts offering long term price targets for Astec Lifesciences Ltd. An average target of ₹1105
Source: S&P Global Market Intelligence
Astec Lifesciences Ltd Share analysis
Astec Lifesciences Ltd price forecast by 2 analysts
Upside of4.69%
High
₹1210
Target
₹1105.00
Low
₹1000
Astec Lifesciences Ltd target price ₹1105, a slight upside of 4.69% compared to current price of ₹1050.7. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Astec Lifesciences Ltd revenue growth forecast
Expected growth rate Q1, FY2026:71.47%
Forecast
Actual
Including amortisation and stock based compensations
Astec Lifesciences Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Astec Lifesciences Ltd Performance
Day's Low
Day's High
₹1,050.05₹1,059.7552 Week's Low
52 Week's High
₹825.05₹1,474.4
| Returns % | |
| 1 Month Return | -2.12 % |
| 3 Month Return | -11.21 % |
| 1 Year Return | -16.24 % |
| Market Stats | |
| Previous Close | ₹1,055.45 |
| Open | ₹1,056.00 |
| Volume | 8,232.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,069.88Cr |
Astec Lifesciences Ltd Key Statistics
| P/E Ratio | -19.98 |
| PEG Ratio | 0.5 |
| Market Cap | ₹2,069.88 Cr |
| P/B Ratio | 5.65 |
| EPS | -23.91 |
| Dividend Yield | 0.14 |
| Sector | Agro Chemicals |
| ROE | -11.93 |
Astec Lifesciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹2,069.88 Cr | 33.05% | 0.79 | -₹47 Cr | ₹458 Cr | |
| NA | ₹4,715.50 Cr | 16.14% | 0.54 | ₹95 Cr | ₹1,044 Cr | |
| ₹6,005.20 Cr | 14% | 0.54 | ₹164 Cr | ₹2,603 Cr | ||
| NA | ₹13.25 Cr | 4.7% | 0.86 | NA | NA | |
| NA | ₹1,204.05 Cr | 19% | 0.64 | ₹53 Cr | ₹934 Cr |
Astec Lifesciences Ltd Mutual Fund Holdings
About Astec Lifesciences Ltd
Its top products include anti-infectives, cardiovascular drugs, anti-diabetics, anti-asthmatics, and anti-malarials. It works under the popular brands of Astec, Astec Care, Astec Health, Astec Life, and Astec Pharma.
Share Price: ₹1050.70 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹2,069.88Cr as of today
Revenue: ₹98.55Cr as on September 2024 (Q3 24)
Net Profit: ₹-38.55Cr as on September 2024 (Q3 24)
Listing date: 25 Nov, 2009
Chairperson Name: N B Godrej
| Organisation | Astec Lifesciences Ltd |
| Headquarters | Mumbai |
| Industry | Agro Chemicals |
| E-voting on shares | Click here to vote |
Key events for Astec Lifesciences Ltd
Astec Lifesciences Reports Decline in Sales and Losses - 28 Oct, 2024
Astec Lifesciences reported standalone net sales of Rs 98.55 crore for September 2024, down 11.05% year-on-year. The company incurred a net loss of Rs 38.57 crore, significantly worse than the previous year's loss. EBITDA also turned negative at Rs 17.75 crore. The stock has seen a decline of 14.70% over the last six months and 11.87% over the past year.
Insights on Astec Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 3.04% to 4.00% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 70.3 Cr → 100.54 Cr (in ₹), with an average increase of 30.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -39.72 Cr → -38.56 Cr (in ₹), with an average increase of 3.0% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 66.75% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Fertilizers & Chemicals Travancore Ltd has given 650.6% return, outperforming this stock by 671.3%
- NO EFFECT
Against Peers
In the last 1 year, Coromandel International Ltd has given 57.6% return, outperforming this stock by 73.9%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 28.84% to 28.21% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 year, ASTEC stock has moved down by -16.2%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 1.03% to 0.53% in Sep 2024 quarter
Astec Lifesciences Ltd Financials
Index Inclusions
Astec Lifesciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 66.75% | ||
| Foreign Institutions | 0.53% | ||
| Mutual Funds | 4% | 31.55 | |
| Retail Investors | 28.21% | ||
| Others | 0.51% | 52.40 |
Astec Lifesciences Ltd Key Indicators
Astec Lifesciences Ltd Valuation
Astec Lifesciences Ltd in the last 5 years
Lowest (-104.01x)
October 6, 2023
Today (-19.98x)
November 19, 2024
Industry (41.37x)
November 19, 2024
Highest (472.00x)
August 31, 2023
Astec Lifesciences Ltd Earnings and Dividends
Astec Lifesciences Ltd Earnings Results
Astec Lifesciences Ltd’s net profit fell -187.12% since last year same period to ₹-38.56Cr in the Q2 2024-2025. On a quarterly growth basis, Astec Lifesciences Ltd has generated 2.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsAstec Lifesciences Ltd Dividends May,2023
In the quarter ending March 2023, Astec Lifesciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.29%.
Read More about Dividends
Astec Lifesciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Astec Lifesciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Astec Lifesciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Astec Lifesciences Ltd shares.
Astec Lifesciences Ltd (ASTEC) share price today is ₹1050.7
Astec Lifesciences Ltd is listed on NSE
Astec Lifesciences Ltd is listed on BSE
- Today’s highest price of Astec Lifesciences Ltd is ₹1059.75.
- Today’s lowest price of Astec Lifesciences Ltd is ₹1050.05.
PE Ratio of Astec Lifesciences Ltd is -19.98
PE ratio = Astec Lifesciences Ltd Market price per share / Astec Lifesciences Ltd Earnings per share
Today’s traded volume of Astec Lifesciences Ltd(ASTEC) is 8,232.00.
Today’s market capitalisation of Astec Lifesciences Ltd(ASTEC) is ₹2069.88Cr.
| Astec Lifesciences Ltd(ASTEC | Price |
|---|---|
52 Week High | ₹1474.4 |
52 Week Low | ₹825.05 |
Astec Lifesciences Ltd(ASTEC) share price is ₹1050.7. It is down -28.74% from its 52 Week High price of ₹1474.4
Astec Lifesciences Ltd(ASTEC) share price is ₹1050.7. It is up 27.35% from its 52 Week Low price of ₹825.05
| Astec Lifesciences Ltd(ASTEC | Returns |
|---|---|
1 Day Returns | -4.75% |
1 Month Returns | -2.12% |
3 Month Returns | -11.21% |
1 Year Returns | -16.24% |